Enterprise record

ANGIODYNAMICS INC logo

ANGIODYNAMICS INC

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:68b0ab90-a96c-4fb4-91ca-e83cadf91de9Version: public-1As of: unavailable

17 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 29, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 28, 2026

    Supports 3 claims
    • Legal Name: ANGIODYNAMICS INC · Claim reviewed: Sep 28, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 28, 2026
    • Published Fact: US · Claim reviewed: Sep 28, 2026

  2. ANGIODYNAMICS INC DEF 14A 2025-09-25

    sec proxy · Source published: Sep 25, 2025 · Retrieved: Apr 24, 2026

    Supports 8 claims
    • Leadership Role: Eileen O. Auen: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Howard W. Donnelly: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: James C. Clemmer: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Jan Stern Reed: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Karen A. Licitra: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Lorinda A. Burgess: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Michael E. Tarnoff, MD: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Wesley E. Johnson, Jr.: Director · Claim reviewed: Sep 28, 2026

  3. ANGO 10-K executive officers

    sec filing · Source published: Jul 18, 2025 · Retrieved: May 14, 2026

    Supports 6 claims
    • Leadership Role: Chad T. Campbell: Senior Vice President and General Manager, Oncology and Interventional Devices · Claim reviewed: Sep 28, 2026
    • Leadership Role: James C. Clemmer: President and Chief Executive Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Laura Piccinini: Senior Vice President and General Manager, Cardiovascular and International · Claim reviewed: Sep 28, 2026
    • Leadership Role: Lawrence T. Weiss: Senior Vice President, Chief Legal Officer Corporate Secretary · Claim reviewed: Sep 28, 2026
    • Leadership Role: Stephen A. Trowbridge: Executive Vice President and Chief Financial Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Warren G. Nighan: Senior Vice President, Global Supply Chain, Quality and Regulatory Affairs · Claim reviewed: Sep 28, 2026